pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 13·1 min read
save

MetALD emerges as a growing U.S. liver crisis linked to obesity, diabetes and heavy drinking, hitting young adults and women

May 13, 2026·read at STAT ↗Negative

U.S. doctors are naming a new liver condition, MetALD, that combines metabolic dysfunction with alcohol related damage. The syndrome reflects the overlap of obesity, diabetes and heavy drinking that is becoming common in the country.

MetALD develops in people who have liver fat and metabolic risk factors such as obesity, pre-diabetes, diabetes, high blood pressure or high cholesterol, together with alcohol intake above ten drinks per week for women or fifteen for men. The proportion of Americans meeting these criteria has more than doubled since 1990.

The disease is strikingly affecting younger adults and women, who are seeing rising rates of serious illness and death. Clinicians warn that many individuals may be unaware of how much they drink, allowing the condition to progress silently.

Public health experts link the surge to the American diet and binge-drinking patterns, calling for greater awareness and preventive measures to curb the growing liver health crisis.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: A new kind of liver crisis is emerging in the U.S. The American diet is to blame”

read at STAT ↗
638 words · retrieved May 13
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADINGRISINGUNIQUE
drugs
Obesity8insulin
topics
Hepatology16Obesity8Endocrinology & Metabolism6Type 2 Diabetes6Hematology2Hyperlipidemia2Hypertension2

related stories

  • Oct 1Opinion: I studied GLP-1 use in children. The results are reassuringSTAT
  • Sep 3‘Tactical athletes’ get new guidance for cardiovascular fitnessSTAT
  • Jul 15Deaths from coronary artery disease have fallen, but more progress is within reachSTAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Sep 22Siemens Healthineers and Novo team up on fatty liver disease awareness, testingFierce Biotech